Atomoxetine Capsule
Product Images NDC 64980-377

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atomoxetine (NDC 64980-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Mean Weight And Height Percentiles Over Time For Patients With Three Years Of Atomoxetine Treatment (Atomoxetine Fig1)

This appears to be a chart or graph showing the Mean Weight Percentile and Mean Height Percentile for two groups (N=203 and N=155) over a period of 36 months of treatment. However, without further context or information, it is difficult to determine the groups being compared or the type of treatment being evaluated.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Capsules Bottle))

This is a medication package containing Atomoxetine capsules. The text provides information about the drug dosage, administration, storage, and safety precautions. The medicine is intended to treat certain mental health conditions, and the package includes a batch and expiry code. The text also instructs pharmacists to dispense the medication with the provided guide.*

FDA Label Image

Package Label-principal Display Panel (18 mg (30 Capsules Bottle))

This is a description of Rising® noc 64980-374-03, which is Atomoxetine Capsules. It contains Atomoxetine hydrochloride USP equivalent to atomoxetine 18 mg. It is distributed by Fising Pharmaceuticals, Inc. and made in India. The ususal dosage is provided in the package insert for dosage and administration. It needs to be kept tightly closed and out of reach of children, with excursions permitted to 15 to 30 degrees Celsius. Batch and expiry details are printed during coding. A pharmacist needs to dispense it and a guide is provided separately.*

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Capsules Bottle))

Each capsule contains Atomoxetine, a drug used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). This medication is distributed by a company named RiSiNG® in India. The capsules come in a dosage strength of 25 mg and should be kept in a cool and dry place, away from children. Further dosage instructions can be found in the package leaflet provided. The text includes a prescription code and additional information regarding packaging and coding.*

FDA Label Image

Package Label-principal Display Panel (40 mg (30 Capsules Bottle))

This text appears to be describing a medication called ZRISING® Noc 61980-376-03. The text provides information on the manufacturer (Made in India) and the dosage and administration of the medication (Atomoxetine). The capsules should be stored at 20° to 25°C. The text also includes a warning to keep the medication out of the reach of children. The medication comes in a package of 30 capsules and the batch and expiry dates will be printed during coding.*

FDA Label Image

Package Label-principal Display Panel (60 mg (30 Capsules Bottle))

Atomoxetine is a medication available in the form of capsules that contain Atomoxstine hycrochloride. Each capsule is equivalent to atomoxatine 60. There are 30 capsules in this package. Pharmacists are advised to dispense this medication with a provided guide. The manufacturer is Gode/’PRAMCAUTICAS’ from India. Store between 20 to 25°C (68 to T7°F); and excursions permitted 1o 16" 10 30°C: (59° 0 86°F). Keep out of reach of children. This product was reviewed in October 2022. Batch and expiry dates will be printed during coding.*

FDA Label Image

Package Label-principal Display Panel (80 mg (30 Capsules Bottle))

Each capsule of Atomoxetine hydrochloric contains 4mg. This medication is manufactured by Rising Pharmaceuticals in East Brunswick, NJ, USA. The code for the drug is TS/DRUGS/10/1693, and the revision date is 0072022. The medication comes with a separate guidance manual, and the dosage is 30 capsules. The information related to batch and expiry will be printed during coding.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Capsules Bottle))

This appears to be a description of a medication in the form of a capsule. The medication is called Somocins and is available in a 30 capsule package, with a dosage and administration guide provided separately. The capsules contain tomoxstin hyckrochlorids USP equivalent to Atomoxetine S bses o, o pemeato o3 and have a NDC number of 64980-379-03. The manufacturer is based in East Brunswick, NJ and the revision date for the information provided is 00/2022. However, the text is not entirely clear and some information may be missing or unclear.*

FDA Label Image

Chemical Structure (Atomoxetine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.